Biliary excretion is an important route for the elimination of some drugs and drug metabolites in man. The factors which determine elimination via the biliary tract include characteristics of the drug such as chemical structure, polarity and molecular size as well as characteristics of the liver such as specific active transport sites within the liver cell membranes. A drug excreted in bile may be reabsorbed from the gastrointestinal tract or a drug conjugate may be hydrolysed by gut bacteria, liberating original drug which can be returned to the general circulation. Enterohepatic circulation may prolong the pharmacological effect of certain drugs and drug metabolites, but the quantitative importance of this in man appears to be less than in animals.
Biliary elimination may play a role in the interindividual differences in drug response observed in healthy subjects and in patients with certain diseases. Cholestatic disease states, in which normal bile flow is reduced, will influence drug elimination by this route resulting in increased risk of drug toxicity. Bile may serve as an alternate route of elimination in renal failure, but this has not been determined in man.
Lack of reliable information regarding the biliary excretion of drugs in man is partly due to the relative inaccessibility of the human biliary tract. Most studies of drug excretion in human bile have been performed in post-surgical patients with T-tube drainage. This method of bile collection is not ideal because bile flow and composition are often severely altered during the period of study, not all bile is collected and enterohepatic circulation is partially interrupted. Recent advances in the methods of collection of bile may improve future studies of drug excretion in human bile.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Abshagen, U.; VonGrodzicki, U.; Hirschberger, U. and Rennekamp, H.: Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man. Naunyn-Schmiedeberg’s Archives of Pharmacology 300: 281–287 (1977).
Acocella, G.; Mattivssi, R.; Nicolis, F.B.; Pallanza, R. and Tenconi, L.T.: Biliary excretion of antibiotics in man. Gut 9: 536–545 (1968).
Acocella, G.; Nicolis, F.B. and Tencooni, L.T.: The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanin green in man. Gastroenterology 49: 521–525 (1965).
Alestig, K.: Studies on the intestinal excretion of doxycycline. Scandinavian Journal of Infectious Disease 6: 265–271 (1974).
Alvan, G.: Individual differences in the disposition of drugs metabolised in the body. Clinical Pharmacokinetics 3: 155–175 (1978).
Andersson, K.E.; Berdahl, B. and Wettrell, G.: Biliary excretion and enterohepatic recycling of proscillaridin A after oral administration to man. European Journal of Clinical Pharmacology 11: 273–276 (1977).
Askin, J.R.; Lyon, D.I.; Shull, S.D.; Wagner, C.I. and Soloway, R.D.: Factors affecting delivery of bile to the duodenum in man. Gastroenterology 74: 560–565 (1978).
Ayliffe, G.A.J. and Davis, A.: Ampicillin levels in human bile. British Journal of Pharmacology 24: 189–193 (1965).
Baird, E.S. and Hailey, D.M.: Delayed recovery from a sedative; correlation of the plasma levels of diazepam with clinical effects after oral and intravenous administration. British Journal of Anaesthesia 44: 803–808 (1972).
Beerman, B.: On the fate of orally administered 3H-Lanatoside C in man. European Journal of Clinical Pharmacology 5: 11–18 (1972).
Beerman, B.; Heistrom, K. and Rosen, A.: Fate of orally administered 3H-digitoxin in man with special reference to the absorption. Circulation 43: 852–861 (1971).
Bell, G.D.; McMullin, J.; Doran, J.; Oliver, J.; McAllister, J.; Ins, F.; Monks, A. and Richens, A.: Ioglycamide(Biligram) studies in man — plasma binding, renal and biliary excretion studies in jaundiced and anicteric patients. British Journal of Radiology 51: 251–256 (1978).
Bickel, M.H. and Minder, R.: Metabolism and biliary excretion of the lipophilic drug molecules, imipramine and desmethylimipramine in the rat. II. Uptake into bile micelles. Biochemical Pharmacology 19: 2437–2443 (1970).
Brogard, J.M.; Haegele, P.; Dorner, M. and Lavillaureix, J.: Biliary excretion of a new semisynthetic cephalosporin, cephacetrile. Antimicrobial Agents and Chemotherapy 3: 19–23 (1973).
Brown, R.B.; Martyak, S.N.; Barza, M.; Curtis, L. and Weinstein, L.: Penetration of clindamycin phosphate into the abnormal human biliary tract. Annals of Internal Medicine 84: 168–170 (1976).
Carruthers, G. and Dujovne, C.A.: Digoxin therapy during T-tube drainage in man. Journal of the American Medical Association 240: 2756–2757 (1978).
Doherty, J.E.; Flanigan, W.J.; Murphy, M.L.; Bulloch, R.I.; Dalrymple, G.L.; Beard, O.W. and Perkins, W.H.: Tritiated digoxin. XIV. Enterohepatic circulation, absorption and excretion studies in human volunteers. Circulation 42: 867–873 (1970).
Douglass, H.O. and Mittleman, A.: Metabolic studies of 5-fluorouracil. II. Influence of route of administration on the dynamics of distribution in man. Cancer 34: 1878–1881 (1974).
Downer, HD.; Galloway, R.W.; Horwich, L. and Parke, D.V.: The absorption and excretion of carbenoxolone in man. Journal of Pharmacy and Pharmacology 22: 449–487 (1970).
Duggan, D.F.; Hare, L.E.; Ditzler, C.A.; Lei, B.W. and Kwan, K.C.: The disposition of sulindac. Clinical Pharmacology and Therapeutics 21: 326–335 (1977).
Duggan, D.F.; Hooke, K.F.; Noll, R.M. and Kwan, K.C.: Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochemical Pharmacology 25: 1749–1754 (1975).
Dunkerley, R.; Johnson, B.S.; Schenker, S. and Wilkinson, G.R.: Gastric and biliary excretion of meperidine in man. Clinical Pharmacology and Therapeutics 20: 546–551 (1977).
Fleischner, G.; Robbins, J. and Arias, I.M.: Immunological studies of Y protein. A major cytoplasmic organic anion-binding protein in rat liver. Journal of Clinical Investigation 51: 677–684 (1972).
Glasko, A.J.; Wolf, L.M.; Dill, W.A. and Bratton, A.C.: Biochemical studies on chloramphenicol (Chloromycetin) II. Tissue distribution and excretion studies. Journal of Pharmacology and Experimental Therapeutics 96: 445–459 (1949).
Herman, R.H.; Rediriger, R.N. and Small, D.M.: The effects of surgery on bile secretion and composition. Surgery Forum 22: 378–380 (1971).
Hirom, P.C.; Milburn, P. and Smith, R.L.: Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica 6: 55–64 (1976).
Hirom, P.C.; Milburn, P.; Smith, R.L. and Williams, R.T.: Studies on the relationship between molecular structure and the biliary excretion of organic compounds. Biochemical Journal 113: 27–28P (1969).
Hirom, P.C.; Milburn, P.; Smith, R.L. and Williams, R.T.: Species variations in the threshold molecular weight factor for the biliary excretion of organic anions. Biochemical Journal 129: 1071–1077 (1972).
Hucker, H.B.; Zacchei, A.G.; Cox, S.V.; Brodie, D.A. and Cantwell, N.H.R.: Studies on the absorption, distribution and excretion of indomethacin in various species. Journal of Pharmacology and Experimental Therapeutics 153: 237–249 (1966).
Jackson, D. V.; Castle, M.C. and Bender, R.A.: Biliary excretion of vincristine. Clinical Pharmacology and Therapeutics 24: 101–107 (1978).
Kaye, C.M.: The biliary excretion of acebutalol in man. Journal of Pharmacy and Pharmacology 28: 449–450 (1976).
Keighley, M.R.B.; Drysdale, R.B.; Quorashi, A.H.; Burdon, D.W. and Alexander-Williams, J.: Antibiotics in biliary disease: Relative importance of antibiotic concentrations in the bile and serum. Gut 17: 495–500 (1976).
Kent, T.H.; Fischer, L.J. and Marr, R.: Glucuronidase activity in intestinal contents of rat and man and relationship to bacterial flora. Proceedings of the Society for Experimental Biology and Medicine 140: 590–594 (1972).
Klaassen, C.D.: Comparison of the effects of two-thirds hepatectomy and bile-duct ligation on hepatic excretory function. Journal of Pharmacology and Experimental Therapeutics 191: 25–31 (1974).
Klaassen, C.D.: Biliary excretion; in Lee (Ed) Handbook of Physiology: Reaction to Environmental Agents, pp.537–553 (American Physiological Society, Washington, D.C 1977).
Klaassen, C.D. and Plaa, G.L.: Effect of carbon tetrachloride on the metabolism, storage and excretion of sulfobromophthalein. Toxicology and Applied Pharmacology 12: 132–139 (1968). 132-139 (1968).
Klotz, U. and Antonin, K.H.: Biliary excretion studies with digoxin in man. International Journal of Clinical Pharmacology 15: 332–334 (1977).
Kunin, C.M. and Finland, M.: Excretion of demethylchlortetracycline into the bile. New England Journal of Medicine 261: 1069–1071 (1959).
Leevy, C.M.; Smith, F.; Longueville, J.; Paumgartner, G. and Howard, M.M.: Indocyanine green clearance as a test for hepatic function. Journal of the American Medical Association 200: 236–240 (1967).
Levitz, M. and Katz, J.: Enterohepatic metabolism of estriol-3-sulfate-16-glucosiduronate in women. Journal of Clinical Endocrinology 28: 862–868 (1968).
Lund, B.; Kampman, J.P.; Lindahl, F. and Hansen, J.M.: Pivampicillin and ampicillin in bile, portal and peripheral blood. Clinical Pharmacology and Therapeutics 19: 587–591 (1976).
Mahon, W.A.; Inaba, T.; Umeda, T.; Tsutsumi, E. and Stone, R.: Biliary elimination of diazepam in man. Clinical Pharmacology and Therapeutics 19: 443–450 (1976).
Meijer, D.K.F.; Vermeer, G.A. and Kwant, G.: The excretion of hexafluorenium in man and rat. European Journal of Pharmacology 14: 280–285 (1971).
Milburn, P.; Smith, R.L. and Williams, R.T.: Biliary excretion of foreign compounds: Biphenyl stilboestrol and phenophthalein in the rat: Molecular weight, polarity and metabolism as factors in biliary excretion. Biochemical Journal 105: 1275–1281 (1967).
Nielsen, M.L. and Justesen, T.: Excretion of metronidazole in human bile. Scandinavian Journal of Gastroenterology 12: 1003–1008 (1977).
Nilsson, H.T.; Persson, C.G.A.; Tegner, K.; Ingemarsson, I. and Liedberg, G.: Biliary excretion of 3H-terbutaline in man. Biochemical Pharmacology 22: 3128–3129 (1973).
Okita, G.I.: Species differences in duration of action of cardiac glycosides. Federation Proceedings 26: 1125–1129 (1967).
Peppercorn, M.A. and Goldman, P.: The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. Journal of Pharmacology and Experimental Therapeutics 181: 555–562 (1972).
Peterson, R.E.; Wyngaarden, J.B.; Guerra, S.L.; Brodie, B.B. and Bunim, J.J.: The physiological disposition and metabolic fate of hydrocortisone in man. Journal of Clinical Investigation 34: 1779–1785 (1955).
Pitt, H.A.; Roberts, R.B. and Johnson, W.D.: Gentamycin levels in the human biliary tract. Journal of Infectious Diseases 127: 299–302 (1973).
Plaa, G.L.: The enterohepatic circulation; in Gillette and Mitchell (Eds) Handbook of Experimental Pharmacology, Vol. 28; part 3, pp.130–149 (Springer-Verlag, Berlin 1975).
Pulaski, E.J. and Fusillo, M.H.: Gallbladder bile concentrations of the major antibiotics following intravenous administration. Surgery, Gynecology and Obstetrics 100: 571–574 (1955).
Ratzan, K.R.; Baker, H.B. and Lauredo, I.: Excretion of cefamandole, cefazolin and cephalothin into T-tube bile. Antimicrobial Agents and Chemotherapy 13: 985–987 (1978).
Riggs, C.E.; Benjamin, R.S.; Serpick, A.A. and Bachur, N.R.: Biliary disposition of adriamycin. Clinical Pharmacology and Therapeutics 22: 234–241 (1977).
Rollins, D.E.; Woodbury, D.W. and Freston, J.W.: Active transport of organic anions into hepatic cells and bile. Gastroenterology 65: 567 (1973).
Russell, J.Q. and Klaassen, C.D.: Biliary excretion of cardiac glycosides. Journal of Pharmacology and Experimental Therapeutics 186: 455–462 (1973).
Sandberg, A.A. and Slaunwhite, W.R.: Metabolism of 4-14C-testosterone in human subjects. I. Distribution in bile, blood, feces and urine. Journal of Clinical Investigation 35: 1331–1339 (1956).
Sandberg, A.A. and Slaunwhite, W.R.: Studies on phenolic steroids in human subjects. II. The metabolic fate and hepato-biliary-enteric circulation of 14C-estrone and 14C-estradiol in women. Journal of Clinical Investigation 36: 1266–1278 (1957).
Sandberg, A.A. and Slaunwhite, W.R.: Studies on phenolic steroids in human subjects. VII. Metabolic fate of estriol and its glucuronide. Journal of Clinical Investigation 44: 694–702 (1965).
Scharschmidt, B.F. and Schmid, R.: The micellar sink. A quantitative assessment of the association of organic anions with mixed micelles and other macromolecular aggregates in rat bile. Journal of Clinical Investigation 62: 1122–1131 (1978).
Schoenfield, L.J.: Biliary secretion of antibiotics. New England Journal of Medicine 284: 1213–1214 (1971).
Sellman, R.; Hurme, M. and Kanto, J.: Biliary excretion of diazepam and its metabolites in man after repeated oral doses. European Journal of Clinical Pharmacology 12: 209–212 (1977).
Smith, R.L.: The Excretory Function of Bile, p.108 (Chapman and Hall, London 1973).
Storstein, L.: Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites. Clinical Pharmacology and Therapeutics 17: 313–320 (1975).
Terhaag, B.; Richter, K. and Diettrich, H.: Concentration behavior of carbamazepine in bile and plasma of man. International Journal of Clinical Pharmacology 16: 607–609 (1978).
Thureborn, E.: Human hepatic bile. Acta Chirurgica Scandinavica Supplement 303: 1–63 (1962).
Yam, J. and Roberts, R.J.: Hepatic uptake of foreign compounds: influence of acute extrahepatic biliary obstruction. Journal of Pharmacology and Experimental Therapeutics 200: 425–433 (1977).
Zaslow, J.: Antibiotics in diseases of the biliary tract. Journal of the American Medical Association 152: 1683–1686 (1953).
About this article
Cite this article
Rollins, D.E., Klaassen, C.D. Biliary Excretion of Drugs in Man. Clin Pharmacokinet 4, 368–379 (1979). https://doi.org/10.2165/00003088-197904050-00003